Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations-Reference-Cited by-同舟云学术

Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations

Published:2017-12-20 Issue:3 Volume:84 Page:419-433
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Goedecke Thomas¹^ORCID,Morales Daniel R.¹²,Pacurariu Alexandra¹³,Kurz Xavier¹

Affiliation:

1. Pharmacovigilance and Epidemiology Department, Inspections Human Medicines Pharmacovigilance and Committees Division; European Medicines Agency (EMA); London E14 5EU UK

2. Division of Population Health Sciences; University of Dundee; Dundee DD2 4BF UK

3. Dutch Medicines Evaluation Board; 3531 AH Utrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13469/fullpdf

Reference172 articles.

1. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies;Bouvy;Drug Saf,2015

2. Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance risk assessment committee;Arlett;Nat Rev Drug Discov,2014

3. Pharmacovigilance Risk Assessment Committee PRAC strategy on measuring the impact of pharmacovigilance activities (Rev 1) (EMA/165407/2017) 2017 http://www.ema.europa.eu/docs/en_GB/document_library/Other/2016/01/WC500199756.pdf

4. Coglianese C Measuring regulatory performance. Evaluating the impact of regulation and policy. Organisation for Economic Co-operation and Development (OECD) http://www.oecd.org/gov/regulatory-policy/1_coglianese%20web.pdf

5. Fifty years of pharmacovigilance - medicines safety and public health;Laporte;Pharmacoepidemiol Drug Saf,2016

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations;Pharmacoepidemiology and Drug Safety;2024-08

2. The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System;Drug Safety;2024-07-10

3. How could employing the patient perspective transform pharmacovigilance?;Expert Opinion on Drug Safety;2024-07-02

4. Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry;Pharmacoepidemiology and Drug Safety;2024-04

5. Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database;European Archives of Psychiatry and Clinical Neuroscience;2024-03-18